9 Analysts Have This To Say About Sangamo Therapeutics
9 Analysts Have This To Say About Sangamo Therapeutics
9位分析師對Sangamo Therapeutics的看法
Diving into Analyst Ratings...9 analysts have shared their evaluations of Sangamo Therapeutics (NASDAQ:SGMO) during the recent three months, expressing a mix of bullish and bearish perspectives.
在最近三個月，9位分析師對Sangamo Therapeutics（納斯達克：SGMO）分享了他們的評估，表達了看好和看淡的混合觀點。
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
下表提供了分析師最近評級的簡明概述，提供了過去30天內情緒變化的洞察，並與前幾個月進行了比較，以便全面了解。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $7.89, a high estimate of $10.00, and a low estimate of $2.00. Observing a 16.37% increase, the current average has risen from the previous average price target of $6.78.
分析師通過對12個月價格目標的評估提供更深層的見解，顯示出平均目標爲7.89美元，最高預估爲10.00美元，最低預估爲2.00美元。觀察到16.37%的增長，目前的平均值從之前的6.78美元的平均價格目標上升了。
Diving into Analyst Ratings...
深入探討...
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間